Baidu
map

Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study

Nettis, E; Ferrucci, SM; Ortoncelli, M; Pellacani, G; Foti, C; Di Leo, E; Patruno, C; Rongioletti, F; Argenziano, G; Macchia, L; Tavecchio, S; Napolitano, M; Ribero, S; Bonzano, L; Romita, P; Di Bona, D; Nistico, SP; Piras, V; Calabrese, G; Detoraki, C; Carbonara, M; Fabbrocini, G

Di Leo, E (通讯作者)，F Miulli Hosp, Sect Allergy & Clin Immunol, Unit Internal Med, Acquaviva Delle Fonti, BA, Italy.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2022; 32 (2): 124

Abstract

Background: Dupilumab has proven to be an effective treatment for patients with moderate-to-severe atopic dermatitis (AD) in clinical trials. However,......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

Baidu
map
Baidu
map
Baidu
map